# FDA 483 - Eric Wolfson, D.O. - August 09, 2018

Source: https://www.globalkeysolutions.net/records/483/eric-wolfson-do/88c79c79-9c4c-425e-969a-eb2e5b1b9ad7

> FDA 483 for Eric Wolfson, D.O. on August 09, 2018. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Eric Wolfson, D.O.
- Inspection Date: 2018-08-09
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - West V
- Summary: An FDA inspection of Eric Wolfson, D.O. in Las Vegas, NV, revealed significant deficiencies in the conduct of clinical investigations. Observations included failures to follow the signed statement of investigator, enrollment of ineligible subjects, unperformed study procedures, and missing critical study documentation. Additionally, investigational drug disposition records were found to be inadequate, lacking proper accountability and reconciliation.

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/rebecca-t-davis/a821f7ef-0c73-4be1-9a9b-3fc2c07f88c1)

Company: https://www.globalkeysolutions.net/companies/eric-wolfson-do/30a0f6b7-811d-48e9-9440-e56089283a3d

Office: https://www.globalkeysolutions.net/offices/division-of-human-and-animal-food-operations-west-v/0f4dd01e-8e8a-4336-9abe-ce8b3d309e8b